Article Details

S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group LLC Review of Late Stage ...

Retrieved on: 2021-03-02 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group LLC Review of Late Stage .... View article details on hiswai:

Excerpt

S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on development of innovative therapies based on central nervous system ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo